Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
0.8% placebo), with total WL of 6.5% compared to 0.8% with placebo [97]
Research in animal models shows activity at approximately 0.5mcg/kg, though human protocols typically use standardized doses in the 1-3mg range regardless of body weight
Research Context DSIP is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and a molecular weight of approximately 848.8 Da
Lastly, the companys return policy is the strictest of the bunch
US$ 26.68
US$ 25.63
US$ 29.78
